Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/ILMN
icon
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Illumina, Inc. (ILMN) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

ILMN trades at $215.59, down 5.31% over 24 hours, yet maintains a bullish technical outlook with strong moving averages. The company reported robust Q2 2026 earnings, beating EPS estimates with $1.31 versus $1.23 expected, and revenue growth of 9.5% year-over-year. Profitability metrics are solid with a net income margin of 18.34% and ROE of 32.34%, though valuation ratios like a P/E of 40.22 suggest a premium. Recent news highlights institutional buying and positive analyst upgrades, supporting momentum in sequencing and oncology markets.
The outlook for ILMN is cautiously optimistic, driven by earnings beats and strategic expansions in multiomics. Key opportunities include sustained margin improvement and market share gains in genomics. Risks involve high valuation multiples and potential margin pressure from cost volatility. Analyst consensus leans bullish with a 51% buy rating, but investors should monitor execution against guidance and competitive dynamics in the biotech sector.
Read full analysis

Key Stats

  • Market Cap
    $32.55B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $227.69
  • 52W Low
    $91.00
  • Typical Hold Time
    -
  • Enterprise Value
    $33.91B
  • Div Yield
    -
  • Trading Activity
    -
$215.59
52W Low: $91
14 Oct 2025
52W High: $227.69
27 Aug 2026

Track Illumina, Inc. (ILMN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Illumina, Inc. has traded between a low of $91 and a high of $227.69, highlighting its annual price range. Buy and sell Illumina, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Illumina, Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Most Recent News

Content is generated by Aura AI

Markets rebound in Q2 2026 with Harbor Human Capital Factor ETF up 11.82% amid easing tensions and strong earnings

In the second quarter of 2026, markets recovered from earlier losses thanks to easing geopolitical tensions, strong corporate earnings, and improved investor sentiment. The Harbor Human Capital Factor US Large Cap ETF gained 11.82%, driven by top per...

Market News
10 hours ago
Seeking Alpha
Bullish
news icon
pluang ai news

Investors in AEVEX urged to act by Oct 19 in securities class action over alleged misleading stock sale claims.

Faruqi & Faruqi, LLP is urging investors who bought AEVEX Corp. securities between April 17, 2026, and April 17, 2026, to consider joining a federal securities class action lawsuit. The lawsuit alleges that AEVEX and its executives misled investors b...

Market News
10 hours ago
Newsfile Corp
Bearish
news icon
pluang ai news

Class action lawsuit filed against Hyliion for misleading investors and insider trading claims.

Rosen Law Firm has filed a class action lawsuit against Hyliion Holdings Corp. for allegedly making false statements and failing to disclose insider trading by its CEO and CFO during May 12 to June 23, 2026. The lawsuit claims that Hyliion announced ...

Market News
15 hours ago
Newsfile Corp
Bearish
news icon
pluang ai news
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $32.55B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $227.69
  • 52W Low
    $91.00
  • Typical Hold Time
    -
  • Enterprise Value
    $33.91B
  • Div Yield
    -
  • Trading Activity
    -
$215.59
52W Low: $91
14 Oct 2025
52W High: $227.69
27 Aug 2026

Track Illumina, Inc. (ILMN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Illumina, Inc. has traded between a low of $91 and a high of $227.69, highlighting its annual price range. Buy and sell Illumina, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!